I just ran into one of the security guards in my building. I asked if she was evacuating. She said: “On my salary, either I can evacuate. Or I can pay my rent on the first. I can’t do both.” I wish more people understood that not everyone has the privilege to evacuate. #Ida

The mentorship on this project was amazing. Super happy to have my first first-author paper out! #surgtwitter #shock

We're on a hot streak! Great job Kelsey Koch & Colette Galet

Welcome to the family!

Our annual General Surgery Residency Picture with Christine Lau in front of the historic Davidge Hall

Really fantastic talk this morning by Marc Besselink. We can all be more collaborative and innovative in our work. It already has me thinking! #pancreaticcancer #pancreas Hopkins Surgery

We are proud to share the Department of Surgery Intern Class of 2024-2025! We are very happy with our match and look forward to a wonderful academic year training the next generation of surgeons!

Time to get the show on the road! IHPBA Joseph R. Habib Ingmar Rompen Brady Campbell, MD MPH

Class is in session with Ammar Asrar Javed, MD PhD 🇺🇸 Should we be doing more Aalen additive regression? Very different factors predict survival over time: early =tumor biology, late = more pre-op patient factors (ECOG, age, etc) The Pancreas Club

Fantastic triple session at The Pancreas Club with Joseph R. Habib, the IPMN derived cancer expert. ✅ T1 substaging validated ⁉️can certain (node negative and normal CA199) forgo adjuvant tx?

Superb session The Pancreas Club 🧬 biology wins. 💉multi-agent chemotherapy improves systemic control. 🩻radiology not accurate after NAT. 😷more aggressive surgery is justified in good biology patients. CUpancreas CU Surgical Oncology

•TP ⬇️ secondary progression/local recurrence in patients with pancreatic cancer arising from multifocal or diffuse IPMN •OS benefit only in young patients •Next: Artificial pancreas to improve postoperative diabetes care #PANORAMAtrial Marc Besselink journals.lww.com/annalsofsurger…

What are the prognostic factors in patients with resected #PDAC that receive NAT? 💊🏥 #PANCPALS published last week in Annals of Surgery ! Key: prognostic factors for OS differ between chemo-naive and NAT patients. Find the prognostic tool on our website soon! 💪

Is there a role for neoadjuvant chemo for 🍇 invasive IPMN ?! 🌎 1k resected only 7% after NAT 👍 BR / LAPC no worse OS after NAT 🧪 CA19.9 indicates “biological” treatment effect 👉journals.lww.com/annalsofsurger…

Congratulations to our newest class of General Surgery Residents! We can't wait to watch you grow! #Match2025 #MatchDay2025 University of Maryland School of Medicine

March Issue: Defining and Predicting Early Recurrence for Optimal Treatment Strategies for Intraductal Papillary Mucinous Neoplasm-Derived #PancreaticCancer : An International Multicenter Study Joseph R. Habib rdcu.be/efnIm David Caba MD,MS,MPH,FACS Syed A. Ahmad

‼️CA 19-9 DELTA FUNCTION 📈 dynamic evaluation over NAT 👍🏻 1️⃣ value never tells the full story 👎🏻 🇫🇷🇺🇸🇮🇹🇳🇱🇬🇧 So proud to be part of this squad PANC-PALS journals.lww.com/annalsofsurger… mδf 🧮 available at pancpals.com/tools

Very lucky to be at #AmerSurg25 for the next few days and hear Dr Weigel’s presidential address. Very cool to see my University of Iowa Surgery roots on the ultimate stage. Annals of Surgery

Followed by another critical session regarding the legal climate on reproductive and health issues. A great idea to include a lawyers’ perspective. #AmerSurg25 Annals of Surgery Jeff Matthews MD

The penultimate #AmerSurg25 presentation by Brady Campbell, MD MPH Jin He: "Mutational Status of Driver Genes in Patients with Resected Pancreatic Ductal Adenocarcinoma Is Associated with Pathological Characteristics and Overall Survival"